Skip to content

Nobel Prize Winner: AI’s Impact On Drug Discovery And Biology | Venki Ramakrishnan

The Peterman Pod

Hosted by Ryan Peterman

42m
Transcript

Original podcast

Where to listen

Summary

Written by a model from the transcript; not yet reviewed.

Nobel Prize winner Venki Ramakrishnan discusses the actual impact of artificial intelligence on drug discovery and molecular biology with host Ryan Peterman. Ramakrishnan argues that while AI successfully predicts protein folding and accelerates initial molecule screening, human biology remains fundamentally more complex than math or computer science, making wet-lab experimentation and clinical trials the ultimate bottleneck. The conversation explores the guest's career pivot from theoretical physics to biology, the nature of scientific taste, and why major awards like the Nobel Prize create a distorted psychological landscape in research.

Listeners will gain a pragmatic view of biotech hype, contrasted with deep insights into how to pick important, feasible scientific problems. Ramakrishnan shares candid reflections on academic credentials, why physicists often struggle when transitioning to life sciences, and how reading Jim Watson's controversial book shifted his perspective on biology as a detective story.

  • Plan your research around a directed random walk, combining a long-term vision with feasible incremental steps. 16:51
  • Choose your academic and professional environment based on the quality of mentors and infrastructure rather than high rankings. 26:12
  • Physicists transitioning into biology must stop thinking solely from first principles and learn to value rigorous control experiments. 27:54
  • Remain open-minded and avoid letting the fear of change trap you in an unproductive professional rut. 41:02

Chapters

  1. 0:00
    Podcast Introduction and Host Greeting

    Ryan Peterman welcomes listeners and introduces Nobel laureate Venky Ramakrishnan, setting the stage for a discussion on AI’s role in drug discovery.

  2. 0:37
    Drug Discovery Workflow and AI Potential

    The conversation shifts to the practical steps of drug design, exploring how AI can generate candidate molecules and the experimental bottlenecks that remain.

  3. 15:17
    AI vs. Human Insight in Choosing Scientific Problems

    The discussion turns to how scientists select meaningful research questions, balancing ambition with feasibility and the human element of curiosity.

  4. 27:03
    Biology’s Complexity vs. Physics’ Predictability

    Ramakrishnan contrasts the experimental, data‑driven nature of biology with the more controlled, theory‑driven approach of physics.

  5. 30:04
    Physicists Entering Biology: Challenges and Opportunities

    He reflects on the difficulties physicists face when transitioning to biology and how their quantitative skills can be both an asset and a hurdle.

  6. 35:11
    The Role of Skill and Genius in Scientific Research

    Ramakrishnan discusses the distinction between skillful training and innate genius, and how both contribute to scientific breakthroughs.

  7. 40:06
    Advice for Aspiring Scientists and Career Flexibility

    He offers personal advice on staying open‑minded, embracing change, and pursuing what genuinely interests you, drawing from his own career path.

Highlights

  • 1:50

    AI Drug Discovery Bottlenecksinsight

    The guest explains that while AI can generate candidate molecules and predict protein structures, the physical experimentation, toxicity prediction, and clinical trials remain the real bottleneck.

  • 7:18

    Biology Versus Mathematics Complexityinsight

    Biology is defined as an intrinsically complex system rather than a defined mathematical one, making organismal prediction far harder for AI models.

  • 10:59

    Punting From Physics To Biologystory

    The guest shares how a lack of motivation and poor career prospects in theoretical physics led him to view a hard pivot into molecular biology as a second chance.

  • 17:59

    Unfashionable Ribosome Researchstory

    After prominent scientists declared basic ribosome mechanisms solved in the 1960s, the guest pursued the unfashionable structural puzzle that eventually led to his Nobel Prize.

  • 27:54

    Control Experiments In Biologyinsight

    Unlike clean physics experiments, complex biological systems demand rigorous control experiments to confirm whether observed changes result from specific interventions.

  • 33:40

    Why Physicists Excel Elsewhereinsight

    Physicists often succeed across diverse technical fields because their training makes them highly comfortable with quantitative thinking, numbers, and complex instrumentation.

  • 35:56

    Psychology Of Pre-Nobelitisinsight

    The guest describes how anticipation around major prizes warps scientific conferences, causing researchers to subtly talk up their own work while ignoring competitors.

Quotes

  • “The experimental part is always going to be the bottleneck.”
    Unnamed speaker · 0:00
  • “I think biology is intrinsically much more complex.”
    Unnamed speaker · 7:18
  • “The principle is that, you know, they've used AI successfully to predict how proteins fold, and that has worked really well.”
    Unnamed speaker · 0:56
  • “You have to combine something that's important with something that's feasible.”
    Unnamed speaker · 16:10
  • “Skill means that you've been very well-trained in the art.”
    Unnamed speaker · 34:36
  • WorkOS 22:31–23:29

About this episode

Venki Ramakrishnan (Molecular biologist, Nobel Prize): "The experimental part [of drug discovery] is always going to be the bottleneck." Recent headlines about using AI to speed up drug discovery made me curious about what that looks like and where it is today. So I flew to the UK to interview Venki Ramakrishnan who is on the scientific advisory board of Demis Hassabis' Isomorphic Labs. He has described himself as a "failed physicist" starting originally with a physics PhD who changed fields because he felt his work was incremental. After pivoting into molecular biology without a degree he discovered the field of work that eventually led to his Nobel prize. So aside from drug discovery, I also asked him about how AI is impacting the field of biology, how biology compares to physics, and the politics behind the Nobel prize. • My ergonomic keyboard project I mentioned, you can follow along here: https://read.compose.llc/ • The Kickstarter page for it: https://www.kickstarter.com/projects/ryanlpeterman/compose-simple-ergonomics-beautifully-done Podcast links: • YouTube: https://www.youtube.com/watch?v=-1q0zA21AkY • Apple: https://podcasts.apple.com/us/podcast/the-peterman-pod/id1777363835 • Transcript: https://www.developing.dev/p/e074-venki-ramakrishnan Thank you to this episode's sponsor for supporting my work: • WorkOS: makes your app Enterprise Ready with easy to use APIs to add SSO, SCIM, RBAC, and more in just a few lines of code, check them out at https://workos.com/ Timestamps: (00:00) Intro (00:43) How drugs are designed (04:54) Why drug testing remains difficult (07:02) How AI will impact the field of biology (10:35) Switching from physics to biology (15:00) How to choose research problems that matter (23:19) Did lacking a credential hurt his career (26:50) Physics vs biology (33:21) Why physicists succeed in other fields (35:10) The politics of the Nobel Prize (38:37) Top scientific book recommendations (40:05) Advice for young people (41:43) Outro Where to find Venki: • Personal website (MRC Laboratory of Molecular Biology): https://mrclmb.ac.uk/research-leaders/venki-ramakrishnan/ • Google Scholar: https://scholar.google.com/citations?hl=&user=oTI5BjIAAAAJ • Royal Society: https://royalsociety.org/people/venki-ramakrishnan-12139/?page=43 • Nobel Prize: https://www.nobelprize.org/prizes/chemistry/2009/ramakrishnan/biographical/ • Wikipedia: https://en.wikipedia.org/wiki/Venki_Ramakrishnan Where to find Ryan: • Newsletter: https://www.developing.dev/ • X/Twitter: https://x.com/ryanlpeterman • LinkedIn: https://www.linkedin.com/in/ryanlpeterman/ • Threads: https://www.threads.com/@ryanlpeterman • Instagram: https://www.instagram.com/ryanlpeterman • TikTok: https://www.tiktok.com/@ryanlpeterman Referenced in this episode: • Isomorphic Labs: https://www.isomorphiclabs.com/ • AlphaFold: https://deepmind.google/science/alphafold/ • AlphaGenome: https://deepmind.google/blog/alphagenome-ai-for-better-understanding-the-genome/ • Neutron-Scattering Studies of the Ribosome (Scientific American, 1976): https://www.scientificamerican.com/article/neutron-scattering-studies-of-the-r/ • Surely You're Joking, Mr. Feynman!: https://wwnorton.com/books/Surely-Youre-Joking-Mr-Feynman/ • The Double Helix: https://www.simonandschuster.com/books/The-Double-Helix/James-D-Watson/9780743216302

Transcript

0:00
42:39

6,603 words · 2 speakers

Speaker names marked are inferred from speaking time and the show’s known hosts — they are not voice-verified.

Topics

  • Ribosome
  • protein
  • mRNA
  • DNA
  • Yale
  • Brookhaven National Lab
  • Ohio University
  • Isomorphic Labs
  • DeepMind
  • The Double Helix

Page updated · transcript and summary are machine-generated